泰国儿童9月龄与2.5岁两剂MMR接种后的抗体纵向研究
泰国2014年将MMR第二剂由6岁提前至2.5岁,本研究在该队列儿童9月龄与2.5岁接种两剂后,于出生、2、7、18、24、36月龄检测麻疹、腮腺炎、风疹IgG。7月龄时96.2%、99.6%、98.8%的婴儿对麻疹、腮腺炎、风疹均无保护;第一剂后三种抗体显著升高,第二剂后未见显著升高;两剂后6个月,麻疹、腮腺炎、风疹分别有97.4%、84.8%、78.7%的儿童保持血清保护。
要点
- 7月龄时绝大多数婴儿母传抗体已消失,麻疹、腮腺炎、风疹无保护比例分别为96.2%、99.6%、98.8%。
- 9月龄首剂后三种抗体显著升高,2.5岁第二剂后未见显著升高。
- 两剂后6个月血清保护率:麻疹97.4%、腮腺炎84.8%、风疹78.7%。
核心结论
- 泰国儿童9月龄与2.5岁两剂MMR接种可诱导对麻疹、腮腺炎、风疹的强免疫应答。
- 两剂后6个月麻疹血清保护率最高,风疹相对较低。
研究设计与样本
- 纵向队列研究,对象为9月龄与2.5岁接种两剂MMR的泰国儿童。
- 队列最初用于评估百日咳杆菌抗原抗体,注册号NCT02408926;母亲曾在孕27–36周接种百白破疫苗。
- 用市售ELISA试剂盒检测出生(脐血)、2、7、18、24、36月龄的抗麻疹、腮腺炎、风疹病毒IgG。
主要发现
- 7月龄时96.2%、99.6%、98.8%的婴儿分别对麻疹、腮腺炎、风疹无保护。
- 第一剂后三种抗原抗体水平显著升高,第二剂后未见显著升高。
- 两剂后6个月,97.4%、84.8%、78.7%的儿童分别对麻疹、腮腺炎、风疹保持血清保护。
关键数值与推荐
- 7月龄无保护比例:麻疹96.2%、腮腺炎99.6%、风疹98.8%。
- 两剂后6个月血清保护率:麻疹97.4%、腮腺炎84.8%、风疹78.7%。
临床怎么用
- 支持泰国9月龄与2.5岁两剂MMR程序可产生较强抗体应答。
- 监测重点可关注第二剂后风疹与腮腺炎血清保护率相对较低的情况。
局限性
- 为单国队列研究,结果外推需谨慎。
- 母亲孕期接种百白破可能影响母传抗体,需结合背景解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Thailand changed the schedule of childhood measles-mumps-rubella (MMR) vaccination in 2014, moving the second dose from the age of 6 years to 2.5 years. There are currently no data on antibody responses to the MMR vaccine since this recommendation. MATERIAL AND METHODS: We investigated antibody responses in a cohort of children who received two doses of MMR vaccine at the ages of 9 months and 2.5 years that was originally established to evaluate antibody levels to Bordetella pertussis antigens (ClinicalTrials.gov no. NCT02408926). Infants were born to mothers who previously received tetanus-diphtheria-acellular pertussis vaccine at 27-36 weeks of gestation. Anti-measles, -mumps, and -rubella virus IgG levels were measured at birth (cord blood) and the ages of 2 and 7 months (before the first MMR vaccination); 18 and 24 months (9 and 15 months, respectively, after the first dose); and 36 months (6 months after the second dose) using commercially available enzyme-linked immunosorbent assay kits. RESULTS: At 7 months of age, 96.2%, 99.6%, and 98.8% of infants had no protection against measles, mumps, and rubella, respectively. Levels of antibody against all three antigens increased significantly after the first but not the second dose. At 6 months after two-dose vaccination, 97.4%, 84.8%, and 78.7% of children remained seroprotected against measles, mumps, and rubella, respectively. CONCLUSIONS: Maternally derived antibodies to measles, mumps, and rubella virus disappeared by the age of 7 months in Thai children. Two-dose MMR vaccination at 9 months and 2.5 years of age induced robust immune responses against these viruses.
引用
- Wanlapakorn N, Puenpa J, Thongmee T, et al. Antibodies to measles, mumps, and rubella virus in Thai children after two-dose vaccination at 9 months and 2.5 years: A longitudinal study. Vaccine. 2020. PMID: 32331806. doi:10.1016/j.vaccine.2020.04.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。